Hartford Financial Management’s VolitionRx Ltd VNRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-250
Closed -$2.85K 370
2025
Q1
$2.85K Hold
250
﹤0.01% 321
2024
Q4
$3K Hold
250
﹤0.01% 338
2024
Q3
$3K Hold
250
﹤0.01% 345
2024
Q2
$3.02K Hold
250
﹤0.01% 343
2024
Q1
$3.79K Hold
250
﹤0.01% 343
2023
Q4
$3.58K Hold
250
﹤0.01% 347
2023
Q3
$3.44K Hold
250
﹤0.01% 343
2023
Q2
$6.95K Hold
250
﹤0.01% 303
2023
Q1
$9.55K Hold
250
﹤0.01% 281
2022
Q4
$12.2K Hold
250
﹤0.01% 272
2022
Q3
$7K Hold
250
﹤0.01% 299
2022
Q2
$10K Hold
250
﹤0.01% 287
2022
Q1
$15K Hold
250
﹤0.01% 269
2021
Q4
$16K Hold
250
﹤0.01% 269
2021
Q3
$16K Hold
250
﹤0.01% 260
2021
Q2
$16K Hold
250
﹤0.01% 262
2021
Q1
$19K Hold
250
﹤0.01% 258
2020
Q4
$19K Hold
250
0.01% 254
2020
Q3
$16K Hold
250
﹤0.01% 245
2020
Q2
$19K Sell
250
-165
-40% -$11.9K 0.01% 245
2020
Q1
$26K Hold
415
0.01% 221
2019
Q4
$39K Hold
415
0.01% 228
2019
Q3
$47K Hold
415
0.02% 213
2019
Q2
$26K Hold
415
0.01% 249
2019
Q1
$27K Buy
415
+40
+11% +$2.23K 0.01% 242
2018
Q4
$14K Hold
375
0.01% 296
2018
Q3
$19K Buy
375
+75
+25% +$3.08K 0.01% 277
2018
Q2
$12K Buy
+300
New +$13.4K ﹤0.01% 313

Other funds holding VNRX

Hartford Financial Management's VNRX Position: Q2 2025 in Review

Hartford Financial Management sold out of VolitionRx Ltd (VNRX) in Q2 2025, closing a stake of 250 shares — an estimated $2.85K sold.

Hartford Financial Management first reported a position in VNRX in Q2 2018 and held it in 28 quarters. The position peaked at $47K in Q3 2019. 29 funds tracked by Wall St. Rank hold VNRX as of Q2 2025.

  • Hartford Financial Management reported no remaining VolitionRx Ltd position as of Q2 2025 after selling out during the quarter.
  • Hartford Financial Management sold 250 VolitionRx Ltd shares in Q2 2025, an estimated $2.85K.
  • Hartford Financial Management first reported a position in VolitionRx Ltd in Q2 2018 and held it in 28 quarters.
  • Hartford Financial Management's VolitionRx Ltd position peaked at $47K in Q3 2019.
  • 29 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q2 2025.

Based on Hartford Financial Management's 13F filing for Q2 2025, filed 31 Jul 2025.